|
Re: Generex Biotechnology provides update on Phase II trial of AE37 breast cancer vac
Still hoping the vaccine will be approved for all levels of Her2 expression, even us 3+ ladies.
Blissfully happy that this is effective for a subset of triple negatives.
|